Vaccine Effectiveness Decline

Researchers uncovered alarming trends showing that vaccinated individuals were increasingly contracting COVID-19, particularly with the rise of the Delta variant. By November, data indicated that the Johnson and Johnson vaccine's effectiveness plummeted to just 13%, while Pfizer and Moderna fared slightly better at around 50%. The team emphasized that breakthrough infections were not limited to older populations, raising concerns about younger individuals potentially spreading the virus to vulnerable family members. As they monitored the situation, the looming threat of Omicron added urgency to their findings.